Regular blood testing is one of the most important ways to maintain good health. In fact, several medical procedures require a blood test as a preliminary requirement. Major medical decisions are taken based on blood tests. The more accurate the blood test results, the better they can aid in the diagnosis.
Blood testing techniques have evolved in recent years with more advanced and accurate results. One of the main types of blood testing is single blood drop analysis. This method is gaining traction as it is inexpensive and easy to use.
According to The International Diabetes Federation (IDF) in 2021, approximately 537 million adults (20-79 years) are living with diabetes and the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. These increasing numbers of diabetes patients across the globe can propel the demand for single blood drop analysis.
What is single blood drop analysis?
The single blood drop analysis is obtained from a finger prick. It has opened wide opportunities for Point-of-Care (POC) technology. This analysis has major potential in POC technology which can be used for various diagnostics such as diabetes, cancer, fertility issues, and for bacterial/ viral infection.
This type of analysis is highly popular in POC devices, especially among diabetes patients for diagnosis and monitoring of blood glucose. It can be done in hospitals, homes, and clinics. Examples of POCTs include the measurement of glucose levels by diabetic patients and home pregnancy tests.
Key Benefits:
There are some key benefits of using this method of analysis which include:
- Real-time diagnostics results within minutes
- Cheaper cost as compared to the lab test
- Help to reduce overall healthcare costs for individual
Why are POC devices gaining rapid traction in the single blood drop method?
Single blood drop analysis has gained rapid traction in recent times due to the rising innovation in POC devices. These types of analytic devices are gaining popularity among home users, especially diabetes patients as these devices show the test results within some minutes after its use.
New home devices for the diagnosis of diabetes such as a smart insulin pen that is a reusable injector pen with an intuitive smartphone app can help people with insulin delivery. Using the finger prtestinick method, patients can easily do the diabetes test on their own with this pen.
Another device is a glucose meter which can help to detect diabetes with a single blood drop method. These methods are made for simpler operations and cheaper rates.
Global Single Blood Drop Analysis Market Size and Valuations
One of the key aspects of market expansion is that patients are preferring single drop blood analysis with POC devices for the diagnosis of disease.
With these trends, the global single-drop analysis market size was USD 22,890 Million in 2021 and is projected to reach around USD 60,971 Million in 2030, expanding at a CAGR of 11.5% during the forecast period, 2022-2030.
Some of the major key players present in the global single blood drop market are Becton, Dickinson and Company; Abbott Laboratories; Siemens; Danaher Corporation; and Roche Holding AG.
Get a Free Sample Report @ https://growthmarketreports.com/request-sample/210
Conclusion
Single blood drop analysis is gaining rapid popularity in blood testing as it provides various advantages such as easy usage, rapid, and more accurate results. The increasing use of this method by diabetic and cancer patients as they can easily do the test at home and POC devices are enabling the use of single drop blood method for blood testing. The most common POC glucose test is glucose testing strips which can give appropriate results.
